YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Healthcare IT Company and Nutritional Products Maker to Work with NFL Alumni Health to Drive Awareness of GLP-1 Telehealth and Pharmacy Services TAMPA, FL / ACCESS Newswire / September 28, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds…
Biotechnology and medical scientific research by Brian A Jackson via Shutterstock DataMEDS AI (MEDS) announced on Sept. 15 that it acquired Helomics and a lab services business, sparking a huge rally in MEDS stock. Shares of MEDS stock gai…
Healthcare stocks were slightly lower late Wednesday afternoon, with the NYSE Healthcare Index fract PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Good morning. Stocks were mixed on Wednesday as oil prices eased but stayed solidly above $100 per barrel ahead of the Federal Reserve's key interest rate decision due this afternoon. Brent crude futures (BZ=F) dropped to $107 per barrel,…
Leading Healthcare IT Company and Former NFL Players Will Work Together to Provide Rural Communities Access to Telehealth and Pharmacy-based Services Through Health Lives Here Mobile App TAMPA, FL / ACCESS Newswire / September 8, 2026 / Da…
* DataMEDS AI press release [https://seekingalpha.com/filing/309963637] (MEDS [https://seekingalpha.com/symbol/MEDS]): Q2 Net loss per share was $7.13 * Revenue was $1.779M in Q2 2026, up 14% sequentially from Q1 2026 and above management…
(RTTNews) - Today's top biotech gainers include Wellgistics following its rebranding, Femasys, which recently resolved its Nasdaq compliance issue, Vor Bio with continued progress in its Telitacicept program, and Sol-Gel Technologies as in…
Leading Health IT Company's Rebranding Reflects Updated Healthcare Ecosystem Aligned with AI Integration to Optimize Patient Control of Healthcare Data TAMPA, Fla., July 21, 2026 /PRNewswire/ -- Wellgistics Health, Inc., (NASDAQ:WGRX), a H…
SARASOTA, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for brain-related health conditions, today provided an update on its strategic progress since…
In this article, we will take a detailed look at the 12 ChatGPT Penny Stock Picks Right Now. For a quick overview of such stocks, read our article5 ChatGPT Penny Stock Picks Right Now. In a world where inflation remains sticky, interest ra…
TAMPA, FL, Nov. 29, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE”), a parent company of a pharmaceutical business-to-business exchange platform, announced today that it received a notice of non-compliance from the N…
TAMPA, FL, Oct. 17, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE”), a parent company of pharmaceutical business-to-business exchange platform, which recently merged with Superlatus, Inc. (“Superlatus”), today reconf…
TAMPA, FL, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Superlatus, Inc. (“Superlatus”), a food technology and distribution company and wholly owned subsidiary of TRxADE HEALTH, Inc. (NASDAQ: MEDS, “TRxADE”), a pharmaceutical exchange platform provid…
Spero is another addition to the growing Superlatus CPG portfolio under their Urgent Company umbrella of brands. Spero® is a plant-based tech company specializing in alternative dairy and egg replacements, on a mission to outcompete tradit…
TAMPA, FL, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Superlatus, Inc., a food technology and distribution company that recently merged with a subsidiary of pharmaceutical exchange platform provider TRxADE HEALTH, Inc. (Nasdaq: MEDS), today announ…
TAMPA, FL, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Superlatus Inc. ('Superlatus' or the 'Company') recently merged with TRxADE HEALTH, Inc. (NASDAQ: MEDS) and is gearing up to revolutionize the snack industry. The Company has unveiled its intent…
Combinedcompany,focusedonsustainable,equitablefoodportfolio,expectedtomore readily penetrate new markets and accelerate transition to animal-free brands Oncecomplete,transactionimmediatelyaccretivetoSuperlatus revenues. TAMPA, FL, Aug. 22,…
TAMPA, FL, Aug. 14, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, today announced that it has filed for an extension to file its Quarterly Report on Form 10-Q for Q2 pu…
Forbes Fisher Appointed as Chief Operating Officer.Dr. Eugenio Bortone Appointed as Chief Innovation & Food Technology Officer. TAMPA, FL, Aug. 03, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc (NASDAQ: MEDS), parent company of pharmaceutica…
NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, today announced the closing of the previously announced acquisition of Superlatus, Inc. (“Superlatus”),…
NEW YORK, July 14, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, announced today that it entered into an amended and restated merger agreement with Superlatus, Inc. (“S…
NEW YORK, June 30, 2023 (GLOBE NEWSWIRE) -- Superlatus, Inc. (“Superlatus”), a U.S.-based holding company of food products and distribution capabilities, announced today that it has signed a definitive agreement to be acquired by TRxADE HE…
NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) -- Superlatus, Inc. (“Superlatus”) (“the Company), a U.S.-based holding company of food products and distribution capabilities, which on June 23, 2023 announced the signing of a binding letter of in…
NEW YORK, June 23, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ:MEDS) (“TRxADE”), a pharmaceutical exchange platform, today announced a correction to its press release issued on Friday, June 23, 2023, 8:05 U.S. Eastern Time, entitl…
NEW YORK, June 23, 2023 (GLOBE NEWSWIRE) -- Superlatus, Inc. (“Superlatus”), a U.S.-based holding company of food products and distribution capabilities, has signed a binding letter of intent (the “LOI”) to be acquired by TRxADE HEALTH, In…
Lutz, Florida, June 21, 2023 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (Nasdaq: MEDS) (the “Company”), today announced that its board of directors has approved a 1-for-15 reverse stock split of its common stock. The reverse stock split will…
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL, May 15, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE” or the “Company”), a health services IT company focused on digi…
Meme stocks represented one of the most remarkable developments in the equities space during much of the new normal. However, by 2022, this sector received a very rude awakening. To be fair, this space enjoys backing from powerful Internet…
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL, Nov. 07, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE” or the “Company”), a health services IT company focused on dig…
TAMPA, FL, Oct. 25, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS)(“TRxADE” or the “Company”) an integrated drug procurement, delivery, and healthcare platform, today announced that Bonum Health, a Digital Healthcare business…
TAMPA, FL, Oct. 03, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS)("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescriptio…
TAMPA, FL, Aug. 30, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS)(“TRxADE” or the “Company”) an integrated drug procurement, delivery, and healthcare marketplace platform that connects buyers and sellers, today announced the…
Natera (NTRA) came out with a quarterly loss of $1.45 per share versus the Zacks Consensus Estimate of a loss of $1.50. This compares to loss of $0.74 per share a year ago. These figures are adjusted for non-recurring items. This quarterly…
DermTech, Inc. (DMTK) came out with a quarterly loss of $1.01 per share versus the Zacks Consensus Estimate of a loss of $0.85. This compares to loss of $0.49 per share a year ago. These figures are adjusted for non-recurring items. This q…
Telemedicine, powered by Bonum Health, provides SpartanNash store guests with direct access to U.S. Board-Certified health providers from smart phones and computers for care at home or on the go To help pharmacy guests find convenient and…
Telemedicine, powered by Bonum Health, provides SpartanNash store guests with direct access to U.S. Board-Certified health providers from smart phones and computers for care at home or on the go To help pharmacy guests find convenient and…